Form D Explorer

Form C/A — Deverra Therapeutics, Inc.

0001665160-24-000977 · filed 2024-06-12 · via StartEngine Capital, LLC

Offering

Target: $14,999
Maximum: $1,234,999
Security type: Common Stock
Price per security: $2.0900
Deadline: —
Oversubscription: Accepted

Issuer

Name: Deverra Therapeutics, Inc.
CIK: 1822782
Entity: Corporation
Jurisdiction: DE
Address: 1600 Fairview Ave E STE 300
Seattle, WA 98102
Phone: —

Most recent fiscal year financials

Total assets

$7,153,624

Cash

—

Short-term debt

$7,222,643

Long-term debt

—

Revenues

$1,677,259

COGS

$1,677,259

Taxes paid

—

Net income

$1,672,096

View original on SEC EDGAR.